跳至主要内容
临床试验/EUCTR2011-005273-23-GB
EUCTR2011-005273-23-GB进行中(未招募)1 期

HEAT-PPCI - How Effective are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention - A randomised controlled trial to compare unfractionated heparin versus bivalirudin in the treatment of patients with a clinical diagnosis of ST-segment elevation myocardial infarction, for planned management with primary PCI - How Effective are Antithrombotic Therapies in Primary PCI: HEATppci v1

iverpool Heart and Chest Hospital0 个研究点目标入组 1,800 人开始时间: 2011年12月12日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients presenting to participating centres with an ST elevation myocardial infarction event with PPCI as the proposed index reperfusion strategy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 900
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 900

排除标准

  • = 18 years of age
  • >12 hours since onset of severe pain
  • Known intolerance, hypersensitivity or contraindication to any trial
  • Active bleeding at presentation
  • Artificial ventilation, reduced conscious level or other factors precluding
  • the administration of oral anti-platelet therapy
  • Previous enrolment in this trial

研究者

发起方
iverpool Heart and Chest Hospital

相似试验